Science

Jul 27, 2025, 13:03

Myeloma Paper of the Day, July 27th, Suggested by Robert Orlowski

Robert Orlowski, Deputy Chair of Lymphoma/Myeloma, Vice Chair of MM Research, and Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:

“Myeloma Paper of the Day:

Novel immune checkpoint inhibitor selectively prevents HLA-E: NKG2A interaction and activates NK cells against tumor cells presenting HLA-E-peptide complexes, potentially minimizing toxicity versus current NKG2A inhibitors.”

Title: HLA-E [pHLA-G] Complex Specific Monoclonal Antibody Enhancing NK Activity in Multiple Myeloma

Authors: Muhammad Abu Ahmad, Olga Radinsky, Bar Kaufman, Kamran Waidha, Eman Gharra, Sharon Dim, Dinesh Babu Manikandan, Noa Ofir, Dirk Jäger, Marten Meyer, Moshe Elkabets, Kerry S. Campbell, Miri Zektser, Roi Gazit, Ory Rouvio, Frank Momburg, Angel Porgador

You can read the Full Article in Blood Advances.

Myeloma Paper of the Day, July 27th, Suggested by Robert Orlowski

You can find more posts featuring Robert Orlowski in OncoDaily.

Angel Porgador Bar Kaufman blood advances cancer Dinesh Babu Manikandan Dirk Jäger Eman Gharra Frank Momburg Kamran Waidha Kerry S. Campbell Marten Meyer Miri Zektser Moshe Elkabets Muhammad Abu Ahmad Myeloma Myeloma Paper of the Day Noa Ofir Olga Radinsky OncoDaily Oncology Ory Rouvio Robert Orlowski Roi Gazit Sharon Dim

Patrick Soon-Shiong: 30 Years and $3B Toward a Universal Cancer Fighter

Vinay Prasad Rejoins FDA Days After Exit

New Paper Alert: Safety and Outcomes of T-DXd Retreatment After Grade 1 ILD Recovery

FDA Accepts NDA for Vepdegestrant in ESR1-Mutant ER+/HER2- Advanced Breast Cancer

Hubert Caron Retires from Roche-Genentech